Establishing secure connection…Loading editor…Preparing document…

Healthcare Study Closure Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE STUDY CLOSURE FORM

Study Identification

Participant Information

Participant ID:

Date of Birth:

Phone:

Emergency Contact:

Emergency Contact Phone:

Insurance Information

Policy Number:

Group Number:

Subscriber Name:

Enrollment and Closure Details

Date Enrolled:

Date of Last Visit:

Primary Reason for Study Closure (check all that apply):

Completed per protocol

Participant withdrawal

Lost to follow-up

Adverse event related to participation

Death

Noncompliance with protocol

Study Treatment and Sample Disposition

Study treatment returned to site

Study treatment destroyed on site

Treatment discontinued at closure

Final Assessments and Medical Status

Final physical exam performed

Final laboratory tests completed

Final ECG completed

Final imaging completed

Adverse Events and Follow-up

Clinical follow-up required

Data and Regulatory Compliance Certification

The site certifies the following statements by initialing or checking each applicable item and by the participant's signature below. These attestations are required to close the participant record in the study database and to archive essential regulatory documentation.

Source documents verified and matched to case report forms

Final CRF completed and signed by investigator/designee

Investigational product accountability completed and reconciled

Regulatory binder and essential documents archived per site procedures

Specimen disposition documented and recorded

HIPAA / Privacy Acknowledgment

By signing below, the participant acknowledges receipt of the privacy notice relevant to this study and authorizes continued retention and limited use of study medical records and biologic samples as required by the protocol and for regulatory purposes. This authorization does not expand disclosure beyond what was consented to at enrollment unless otherwise specified below.

Participant acknowledges HIPAA/privacy notice and ongoing data retention for study purposes

Participant Statement and Certification

I certify that the information I have provided on this form is true and complete to the best of my knowledge. I understand that by signing this form I acknowledge the study record for my participation is closed. I understand my right to withdraw from the study and that closure of my record will not affect my right to receive medical care. If signing as a legal guardian or authorized representative, I certify I have the legal authority to sign on behalf of the participant and that relationship is stated below.

Participant Name (print):

Relationship (if guardian or representative):

Signature:

Date:

Enter text✕

What the Healthcare Study Closure Form Is

The Healthcare Study Closure Form documents formal termination of a clinical or observational study, summarizing final enrollment, data disposition, adverse events, and regulatory notifications. It records the date the study closed to accrual, confirms completion or discontinuation of study activities, and documents final responsibilities for data retention, participant follow-up, and sponsor reporting. This form is used to notify institutional review boards (IRBs), sponsors, clinical trial registries, and internal compliance teams that the protocol has ended and to begin post-study closeout steps such as archive and disposition of identifiable health information.

Why a Complete Closure Form Matters

A thorough Healthcare Study Closure Form ensures regulatory compliance, documents final safety data, and triggers required notifications and record retention processes. Accurate closure records reduce audit risk and support reproducible post-study data management.

Why a Complete Closure Form Matters

Who Typically Prepares and Receives This Form

Research coordinators, principal investigators, sponsors, and IRB administrators usually complete and receive study closure forms to confirm protocol completion and compliance.

  • Principal Investigator: Submits closure rationale, confirms data integrity, and certifies follow-up responsibilities.
  • Research Coordinator: Compiles enrollment numbers, adverse event summaries, and supporting documentation for closure.
  • IRB / Compliance Office: Reviews closure documentation, confirms regulatory notifications, and updates study status.

Distribution typically follows institutional workflows; retain copies in both the study master file and the institutional records system for the required retention period.

Signatories and Their Roles

Principal Investigator

The PI certifies study closure facts, confirms that participant safety follow-up obligations are met, and signs to attest to accuracy. The PI is accountable for submitting final reports to the IRB and sponsor as required by protocol and regulations.

Sponsor Representative

The sponsor approves study termination, confirms data transfer and archiving instructions, and signs to accept final data stewardship responsibilities and any financial reconciliations required by contract.

Essential Data Elements to Include

Study Identifier: Protocol number
Effective Date: Closure date
Reason for Closure: Completion, termination, or suspension
Final Enrollment: Total participants
Data Disposition: Archive location
Signatures: Authorized signers

Risks of Incomplete or Incorrect Closure Records

Regulatory Noncompliance: Delayed IRB or sponsor reporting can lead to corrective actions or sanctions
HIPAA Violations: Improper data disposition risks breaches and HIPAA penalties
Audit Findings: Incomplete documentation increases likelihood of audit citations
Financial Exposure: Contractual noncompliance may trigger clawbacks or penalties
Participant Safety: Failure to document follow-up obligations can harm participant welfare
Loss of Data Integrity: Poor version control undermines reproducibility

Common Preparation Pitfalls to Avoid

  • Missing or mismatched protocol identifiers that delay reviewer acceptance.
  • Incomplete adverse event summaries that require follow-up and re-submission.
  • Incorrect retention instructions for PHI leading to noncompliant storage.
  • Failure to obtain required signatures or attestations before submission.

Step-by-Step: Completing the Closure Form

Follow these core steps to prepare a compliant Healthcare Study Closure Form and trigger downstream closeout activities.

  • 01
    Verify Study Details: Confirm protocol number and title
  • 02
    Summarize Outcomes: Record final enrollment and key results
  • 03
    Report Safety: Include final adverse event disposition
  • 04
    Sign and Distribute: Collect required approvals and route copies

Typical Submission and Routing Flow

Closure forms usually follow a multi-step routing process within research administration and sponsor systems.

  • Local Review: Coordinator compiles form for PI review
  • PI Approval: PI signs and confirms responsibilities
  • IRB Notification: Submit to IRB per policy
  • Sponsor / Registry: Notify sponsor and update trial registry

Key Sections a Professional Closure Form Should Contain

A complete Healthcare Study Closure Form is structured to capture administrative, scientific, and regulatory facts that support auditability and follow-up.

Administrative Header

Study title, protocol number, sponsor, and site identifiers for unambiguous record linkage.

Closure Summary

Effective closure date, closure type (completed, terminated), and brief rationale for termination or completion.

Enrollment and Outcomes

Final participant counts, primary endpoint status, and any protocol deviations impacting analysis.

Safety and Adverse Events

Aggregate adverse event summary and actions taken for participant safety and reporting.

Data and Records

Location of master files, data archive procedures, access controls, and data sharing restrictions.

Approvals and Signatures

Authorized PI, sponsor representative, and compliance officer signatures with dates and titles.

Practical Tips for Accurate and Efficient Completion

Use consistent identifiers and centralized templates to reduce errors and speed reviews.

Use Standard Templates
Adopt institution-approved templates to ensure required fields are present and correctly formatted.
Cross-Check Data
Verify enrollment and AE tallies against source systems before finalizing the form.
Plan Data Disposition
Include explicit archive location, retention period, and access permissions to prevent ambiguity.
Record Versioning
Store signed PDF with audit trail and maintain an editable master for internal records only.

Timing Considerations and Typical Deadlines

Closure timing drives when notifications and reports must be filed; be aware of institutional and regulatory deadlines.

IRB Reporting Window:

Submit closure summary per IRB policy, typically within 30 days

ClinicalTrials.gov:

Update status within 30 days for applicable interventional trials

Sponsor Notification:

Notify sponsor per contract terms, commonly within 14–30 days

Data Transfer:

Complete sponsor data handover per the data management plan

Final Financial Reconciliation:

Close budgets and invoices within the sponsor-agreed timeframe

eSignature Vendor Pricing and Feature Snapshot

Compare basic pricing and select compliance features relevant to healthcare study closure workflows; signNow is listed first for parity with available plan data.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes (BAA required) Yes Yes No No
Envelope Cap No envelope cap 100 envelopes/user/year limit Varies by plan Varies by plan Varies by plan

Frequently Asked Questions About Closure Forms and eSigning

Answers to common questions about legal validity, signatures, notarization, and recordkeeping when closing a healthcare study.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users